Stratifying patients for polypharmacy interventions: The case for a new biomarker?
- PMID: 34599530
- DOI: 10.1111/bcp.15083
Stratifying patients for polypharmacy interventions: The case for a new biomarker?
Comment on
-
Using soluble urokinase plasminogen activator receptor to stratify patients for medication review in the emergency department.Br J Clin Pharmacol. 2022 Feb;88(4):1679-1690. doi: 10.1111/bcp.14982. Epub 2021 Aug 2. Br J Clin Pharmacol. 2022. PMID: 34242432
References
REFERENCES
-
- Bloomfield HE, Greer N, Linsky AM, et al. Deprescribing for community-dwelling older adults: a systematic review and meta-analysis. J Gen Intern Med. 2020;35(11):3323-3332. https://doi.org/10.1007/s11606-020-06089-2
-
- Huiskes VJB, Burger DM, Van Den Ende CHM, Van Den Bemt BJF. Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials. BMC Fam Pract. 2017;18(1):5. https://doi.org/10.1186/s12875-016-0577-x
-
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. http://www.sciencedirect.com/science/article/pii/0021968187901718
-
- Threapleton CJD, Kimpton JE, Carey IM, et al. Development of a structured clinical pharmacology review for specialist support for management of complex polypharmacy in primary care. Br J Clin Pharmacol. 2020January;86(7):1-10. https://doi.org/10.1111/bcp.14243
-
- Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Intern Med. 2019;179(8):1084-1093. https://doi.org/10.1001/jamainternmed.2019.0677
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources